Warning: simplexml_load_string(): Entity: line 39: parser error : Input is not proper UTF-8, indicate encoding ! Bytes: 0xC2 0x26 0x23 0x38 in /mnt/ebs/scidaily/public_html/video.php on line 916 Warning: simplexml_load_string(): d time-consuming. So why not bring the doctor to the patient - digitally?     in /mnt/ebs/scidaily/public_html/video.php on line 916 Warning: simplexml_load_string(): ^ in /mnt/ebs/scidaily/public_html/video.php on line 916 Warning: Invalid argument supplied for foreach() in /mnt/ebs/scidaily/public_html/video.php on line 919 Warning: DOMNode::appendChild(): Document Fragment is empty in /mnt/ebs/scidaily/public_html/video.php on line 497 Pfizer's bid is too bitter for Astra -- ScienceDaily

Science Videos

from AP, Reuters, AFP, and other news services

Pfizer's bid is too bitter for Astra

Date:
May 19, 2014
Source:
Reuters - Business Video Online / Powered by NewsLook.com
Summary:
Britain's AstraZeneca has rejected a sweetened offer from Pfizer. But could they live to reject turning down the U.S. drugmaker's plan to create the world's biggest pharmaceuticals group? Ciara Sutton reports Video provided by Reuters


Related Videos

last updated on 2014-07-30 at 9:41 pm EDT

Big Pharma Braces for M&A Wave

Big Pharma Braces for M&A Wave

Reuters - Business Video Online (Apr. 22, 2014) — Big pharma on the move as Novartis boss, Joe Jimenez, tells Reuters about plans to transform his company via an asset exchange with GSK, and Astra Zeneca shares surge on speculation that Pfizer is looking for a takeover. Joanna Partridge reports. Video provided by Reuters
Powered by NewsLook.com
Pfizer Needs AstraZeneca More Than Ever as Generics Increase

Pfizer Needs AstraZeneca More Than Ever as Generics Increase

TheStreet (May 5, 2014) — Pfizer shares are slipping after the drug maker posted first-quarter profits 15% lower than a year earlier and revenue down 9%. Net income of 57 cents a share beat expectations by 2 cents, but $11.3 billion in sales fell short of analysts' estimates of $12.1 billion. The weaker-than-expected report comes days after its latest offer to purchase British drug maker AstraZeneca for $106 billion was rejected. Pfizer has seen lost profits on greater competition from generic brands on the market. Video provided by TheStreet
Powered by NewsLook.com
Pfizer's Profit Drops 15 Pct

Pfizer's Profit Drops 15 Pct

Reuters - Business Video Online (May 5, 2014) — Profit and revenue fell at Pfizer as generic drugs ate away at Lipitor and other products whose patents have expired. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
So Why Did AstraZeneca Reject Pfizer?

So Why Did AstraZeneca Reject Pfizer?

Reuters - Business Video Online (May 19, 2014) — AstraZeneca's Chairman explains why the UK drugmaker's board rejected a final "sweetened" offer from Pfizer. (Rough Cut - no reporter narration) Video provided by Reuters
Powered by NewsLook.com

Related Stories


Share This



Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins